We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simultaneous Completion of First Genomes of a Wild Plant

By LabMedica International staff writers
Posted on 30 Oct 2008
Print article
Researchers reported the simultaneous completion of the first genomes of wild Arabidopsis thaliana strains as part of the 1,001 Genomes Project.

Researchers from the Max Planck Institute for Developmental Biology (Tuebingen, Germany) recently announced the completion of the first genomes of wild strains of the flowering plant known as the thale cress or mouse-ear cress or formally A. thaliana. The entire genomes of two individuals of this species, one from Ireland, the other from Japan, have now been compared in detail. They were found to be remarkably different from each other, as Dr. Detlef Weigel and his colleagues wrote in the September 25, 2008, issue of the journal Genome Research.

This study marks the starting point of the 1,001 Genomes Project in which 1,001 individuals of the same species will be sequenced. The scientists are trying to correlate the genetic differences between the different strains with variation in the speed of plant growth and their resistance against infectious germs. These strategies could then also be applied to crop plants or trees.

Every genome is different. It is well known that the genome of apes must be different from the human genome and that both are different from the genome of a sunflower. It is only a few years ago that a huge research community produced at great cost a single human genome sequence. The hypothesis was that it would unlock all the fundamental characteristics of humans, since any differences between individuals were believed to be very slight, on the order of 0.1% of the entire genome.

Similar assumptions prevailed for other species, including thale cress A. thaliana, a model organism in plant science. It is one of the best-understood organisms on earth; however, the genetic differences that allow different strains of this plant to thrive in very different places all over the Northern hemisphere are largely unknown.

Until very recently, it was theorized that the similarity in appearance of different individuals of thale cress is correlated by a comparable level of similarity in the genetic material. "But is it really true that such subtle differences in our DNA or in that of thale cress can account for the great variation in individual traits? Is there indeed something like ‘the' genome of a species, or do have to change our point of view and focus on the genome of an individual?” asked Dr. Weigel, director of the Max Planck Institute for Development Biology.

Recent developments in the technology of DNA sequencing have reduced the cost for reading a single genome by several orders of magnitude, and this can now be accomplished within a week, instead of months or years. However, there are still few analytic tools for the surge of data produced by the new generation of sequencing machines, such as the one sold by the San Diego, CA, USA-based company Illumina. The Max Planck Institute group had to overcome a series of technical challenges to reconstruct the genome sequences of the two strains it analyzed from the relatively short snippets of sequences that the Illumina instrument delivers. But the first feasibility study has now been finished, demonstrating that even with these very short sequence reads not only point differences can be identified, but also missing or extra genetic material can be tracked down. "We are confident that our method is robust, and we have begun to sequence the genomes of 80 thale cress strains,” stated Dr. Weigel. The project could be finished by January 2009.

The study marks the start of a project on a much larger scale. Within the next two years the 1,001 Genomes project, led by Dr. Weigel, plans to sequence at least 1,001 different thale cress individuals from around the world. The hope is that equipped with this information, it will be possible to correlate genetic differences with variation in the speed with which plants grow, how much they branch, or how well they resist infectious germs. This project, in turn, will inform similar projects on crop plants, which have much larger genomes and are therefore more difficult to analyze.

While this is very promising, the task will not be completed once every individual genome is sequenced. In every cell, the genomes are packaged in different ways, allowing for different activities of the same genetic material. With the next sequencing techniques, these subtle differences can be studied as well. Thus, the 1,001 Genomes project will strip away only the first layer of variation.

Related Links:
Max Planck Institute for Developmental Biology
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Flu Test
ID NOW Influenza A & B 2
New
Flow Cytometer
BF – 710

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Small molecule modulation of protein corona significantly enhances deep plasma proteome profiling (Photo courtesy of Mahmoudi Group)

Smarter Blood Tests Deliver Faster Diagnoses and Improved Outcomes

It has long been established that the earlier a disease is detected, the better the chances for a positive patient outcome. A novel method now offers an in-depth analysis of proteins in plasma, uncovering... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.